Mike Matson
Stock Analyst at Needham
(2.43)
# 2,282
Out of 4,791 analysts
506
Total ratings
42.29%
Success rate
-1.13%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRC AtriCure | Reiterates: Buy | $51 | $33.58 | +51.90% | 33 | Mar 27, 2025 | |
| TMDX TransMedics Group | Reiterates: Hold | n/a | $71.99 | - | 8 | Mar 26, 2025 | |
| OCX OncoCyte | Reiterates: Buy | $4.25 | $2.93 | +45.05% | 16 | Mar 25, 2025 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $2.5 → $3 | $1.47 | +104.78% | 17 | Mar 24, 2025 | |
| SYK Stryker | Reiterates: Buy | $442 | $373.54 | +18.33% | 8 | Mar 21, 2025 | |
| HAE Haemonetics | Maintains: Buy | $108 → $104 | $63.43 | +63.97% | 12 | Mar 18, 2025 | |
| LIVN LivaNova | Reiterates: Buy | $64 | $39.30 | +62.85% | 25 | Mar 17, 2025 | |
| TFX Teleflex | Reiterates: Hold | n/a | $141.14 | - | 9 | Mar 12, 2025 | |
| KIDS OrthoPediatrics | Reiterates: Buy | $42 | $25.61 | +64.00% | 21 | Mar 5, 2025 | |
| BSX Boston Scientific | Reiterates: Hold | n/a | $100.42 | - | 27 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7.25 → $7 | $3.71 | +88.93% | 19 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.16 | - | 17 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $64 | $35.86 | +78.47% | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $122 → $116 | $106.31 | +9.11% | 24 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $169.74 | - | 24 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $32 | $24.65 | +29.84% | 16 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $30.40 | +67.76% | 16 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $276.20 | - | 10 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $88.44 | - | 17 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $18 | $9.56 | +88.28% | 24 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $112.44 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $60.54 | - | 19 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $91 | $60.53 | +50.34% | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $18.12 | - | 16 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $221.95 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $30.72 | - | 20 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $13 | $13.07 | -0.54% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $141.43 | - | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $226.55 | - | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $14.17 | +196.40% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $74.92 | +0.11% | 1 | Feb 18, 2021 |
AtriCure
Mar 27, 2025
Reiterates: Buy
Price Target: $51
Current: $33.58
Upside: +51.90%
TransMedics Group
Mar 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $71.99
Upside: -
OncoCyte
Mar 25, 2025
Reiterates: Buy
Price Target: $4.25
Current: $2.93
Upside: +45.05%
Lucid Diagnostics
Mar 24, 2025
Maintains: Buy
Price Target: $2.5 → $3
Current: $1.47
Upside: +104.78%
Stryker
Mar 21, 2025
Reiterates: Buy
Price Target: $442
Current: $373.54
Upside: +18.33%
Haemonetics
Mar 18, 2025
Maintains: Buy
Price Target: $108 → $104
Current: $63.43
Upside: +63.97%
LivaNova
Mar 17, 2025
Reiterates: Buy
Price Target: $64
Current: $39.30
Upside: +62.85%
Teleflex
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $141.14
Upside: -
OrthoPediatrics
Mar 5, 2025
Reiterates: Buy
Price Target: $42
Current: $25.61
Upside: +64.00%
Boston Scientific
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $100.42
Upside: -
Feb 28, 2025
Maintains: Buy
Price Target: $7.25 → $7
Current: $3.71
Upside: +88.93%
Feb 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.16
Upside: -
Feb 27, 2025
Maintains: Buy
Price Target: $65 → $64
Current: $35.86
Upside: +78.47%
Feb 26, 2025
Maintains: Buy
Price Target: $122 → $116
Current: $106.31
Upside: +9.11%
Feb 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $169.74
Upside: -
Feb 25, 2025
Maintains: Buy
Price Target: $34 → $32
Current: $24.65
Upside: +29.84%
Feb 25, 2025
Reiterates: Buy
Price Target: $51
Current: $30.40
Upside: +67.76%
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $276.20
Upside: -
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $88.44
Upside: -
Feb 19, 2025
Maintains: Buy
Price Target: $19 → $18
Current: $9.56
Upside: +88.28%
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $112.44
Upside: -
Feb 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $60.54
Upside: -
Feb 6, 2025
Maintains: Buy
Price Target: $97 → $91
Current: $60.53
Upside: +50.34%
Feb 4, 2025
Maintains: Hold
Price Target: n/a
Current: $18.12
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $221.95
Upside: -
Jan 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $30.72
Upside: -
Jan 29, 2025
Downgrades: Hold
Price Target: $13
Current: $13.07
Upside: -0.54%
Nov 13, 2024
Reiterates: Hold
Price Target: n/a
Current: $141.43
Upside: -
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $226.55
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $14.17
Upside: +196.40%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $74.92
Upside: +0.11%